Is the SMART risk prediction model ready for real-world implementation? A validation study in a routine care setting of approximately 380 000 individuals.

Ailsa J McKayLaura H GunnBrian A FerenceJannick A N DorresteijnGijs F N BerkelmansFrank L J VisserenKausik K Ray

Published in: European journal of preventive cardiology (2021)

The performance of the SMART model in this validation cohort demonstrates its potential utility in routine healthcare settings in guiding both population and individual-level decision-making for secondary prevention patients.

Keyphrases

healthcare
decision making
end stage renal disease
newly diagnosed
clinical practice
quality improvement
ejection fraction
primary care
palliative care
prognostic factors
patient reported outcomes
pain management
health insurance
patient reported